Matej Medvecký
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 19
- Endocrinology top 2%
- Enterobacteriaceae and Cronobacter Research 10
- Infections and bacterial resistance 6
- Vibrio bacteria research studies 3
- Pollution top 10%
- Pharmaceutical and Antibiotic Environmental Impacts 4
- Clinical Biochemistry top 10%
-
- Bacteriophages and microbial interactions 5
- Microbial Community Ecology and Physiology 3
-
- Bacterial biofilms and quorum sensing 4
- Co-authors
- Jaroslav HrabákCostas C. PapagiannitsisOndřej PolanskýIvan Rychlı́kMonika DolejskáTereza KubasováHelena ŽemličkováVladislav Jakubů
- Journals
- PLoS ONE (2 papers)Antimicrobial Agents and Chemotherapy (7 papers)Frontiers in Microbiology (3 papers)
- Partner nations
- CzechiaGreeceUnited Kingdom
In The Last Decade
Matej Medvecký
32 papers receiving 728 citations
Peers
Comparison fields: 5 of 73
- Molecular Medicine 410
- Endocrinology 203
- Applied Microbiology and Biotechnology 47
- Pollution 137
- Clinical Biochemistry 66
Countries citing papers authored by Matej Medvecký
This map shows the geographic impact of Matej Medvecký's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matej Medvecký with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matej Medvecký more than expected).
Fields of papers citing papers by Matej Medvecký
This network shows the impact of papers produced by Matej Medvecký. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matej Medvecký. The network helps show where Matej Medvecký may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matej Medvecký, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 15 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 8 | |
| 7 | 2021 | 19 | |
| 8 | 2020 | 36 | |
| 9 | 2020 | 4 | |
| 10 | 2019 | 17 | |
| 11 | 2019 | 10 | |
| 12 | 2018 | 1 | |
| 13 | 2018 | 11 | |
| 14 | 2018 | 113 | |
| 15 | 2018 | 3 | |
| 16 | 2018 | 20 | |
| 17 | 2018 | 57 | |
| 18 | 2017 | 18 | |
| 19 | 2017 | 51 | |
| 20 | 2016 | 23 |
About Matej Medvecký
Matej Medvecký is a scholar working on Molecular Medicine, Endocrinology and Microbiology, having authored 34 papers that have together received 731 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (19 papers), Enterobacteriaceae and Cronobacter Research (10 papers), Infections and bacterial resistance (6 papers), Bacteriophages and microbial interactions (5 papers), Pharmaceutical and Antibiotic Environmental Impacts (4 papers), Bacterial biofilms and quorum sensing (4 papers), Microbial Community Ecology and Physiology (3 papers) and Vibrio bacteria research studies (3 papers). The work is most often cited by research in Molecular Medicine (410 citations), Endocrinology (203 citations) and Applied Microbiology and Biotechnology (47 citations). Matej Medvecký has collaborated with scholars based in Czechia, Greece and United Kingdom. Frequent co-authors include Jaroslav Hrabák, Costas C. Papagiannitsis, Ondřej Polanský, Ivan Rychlı́k, Monika Dolejská, Tereza Kubasová, Helena Žemličková, Vladislav Jakubů, Kateřina Chudějová and Darina Čejková. Their work appears in journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.